Human Organoids Market: By Product (Liver, Kidney, Pancreas, Colorectal, Heart, Others), By Application (Developmental biology, Drug toxicity & efficacy testing, Disease pathology, Personalized medicine, Regenerative medicine, other application), By Usability (Ready to use products, Customizable products) By End Users (Pharmaceutical & Biotechnology companies, CROs, Academic & Research Institutes, Others) and Geography - Human Organoids Market Report Description

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Human Organoids Market size was expected to be worth USD 2,164.6 million in 2022 and is projected to grow at a 16.2% CAGR from 2023 to 2029. Organoids are stem cell-derived, small, self-organized three-dimensional tissue cultures. Such cultures can be designed to reproduce much of an organ's complexity or express specific features, such as producing only certain types of cells. Organoids develop from stem cells, which can proliferate endlessly and have various cell types as part of their progeny. Organoids range from less than a hair's breadth to five millimetres. Based on the product type, the global human organoid market is segmented into Liver, Kidney, Pancreas, Colorectal, Heart, and Others. The Liver segment is anticipated to grow at a significant CAGR over the forecast years, owing ascribed to greater acceptance of new technologies among academics and academia (combined with expanding industry-academia cooperation for genomic research), technological breakthroughs in 3D bioprinting, and an increase in the number of liver transplants and disorders. Factors such as market technology improvements are driving the expansion of the human organoids industry. Furthermore, increased transplant cases and investments from both the commercial and public sectors are influencing the growth of the human organoids industry.

Human Organoids Market Key Developments:
In May 2020, The Luxembourg Centre for Systems Biomedicine researchers built an organoid that can be used to study Parkinson's disease.

Human Organoids Market Summary

Study Period

2023– 2029

Base Year




Largest Market

Asia Pacific

Fastest Growing Market

North America
Human Organoids Market Dynamics

Animal models are commonly employed in human-specific scientific research. However, numerous situations show that animal models are not necessarily predictive of human drug response, such as in drug toxicology research. This is because the metabolism of medications and poisons differs significantly between humans and animals, making it practically hard to research drug metabolism in experimental models such as laboratory rodent species. Furthermore, various restrictions have been adopted in recent years that limit the use of animals in scientific operations worldwide. Similarly, some organizations, including Cruelty-Free International and the Fund for the Replacement of Animals in Medical Experiments, are against using animal-based models in research. It is vital to design alternative testing models to give an environment as close to the human body as possible. Various institutes are active in establishing alternate approaches for medication development and biological research considering this. Because organoids can be used instead of animal models in research, the current emphasis on minimizing animal use in research is projected to help the growth of the human organoids industry.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Human Organoids Market Segmentation

By product type
  • Liver
  • Kidney
  • Pancreas
  • Colorectal
  • Heart
  • Others
By Application
  • Developmental biology
  • Drug toxicity & efficacy testing
  • Disease pathology
  • Personalized medicine
  • Regenerative medicine
  • Other application
By Usability
  • Ready to use products
  • Customizable products 
By End User
  • Pharmaceutical & Biotechnology companies
  • CROs
  • Academic & Research Institutes
  • Others
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA


Frequently Asked Questions

The growth in the clinical microbiology market is driven majorly by the rising incidence of transplants and technological advancements in human organoids, and increased funding and public-private investments.

The liver segment by type will show the most opportunity for growth.

BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US), Corning (US), Organovo (US), Cyprio (France), Biopredic International (France), CELLINK (Sweden) are the leading players in the global Organoids market.

The lack of skilled professionals to conduct diagnostic tests and insufficient funding for research & academia are estimated to hamper the market growth.

  • BioIVT (US)
  • Thermo Fisher Scientific (US)
  • ZenBio (US), Corning (US)
  • Organovo (US)
  • Cyprio (France)
  • Biopredic International (France)
  • CELLINK (Sweden)
  • Emulate (US)
  • Hµrel Corporation (US)
  • InSphero (Switzerland)
  • Kerafast (US)
  • Kirkstall (UK)